Research Database

290 studies found

Positive

109

37.6%

Negative

7.6%

Inconclusive

141

48.6%

Page 9 of 15

InconclusiveReview/Other

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

2023

AddictionAddictionCOVID-19+8

PositiveDouble Blind Clinical Trial

Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial

2023

COVID-19

PositiveReview/Other

Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome

2023

Cognitive Dysfunction

PositiveReview/Other

Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

2022

COVID-19

PositiveReview/Other

Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities

2022

Addiction

PositiveDouble Blind Clinical Trial

Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial

2022

COVID-19

NegativeReview/Other

Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest

2022

COVID-19

NegativeReview/Other

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

2022

Addiction

PositiveReview/Other

Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

2022

COVID-19

PositiveDouble Blind Clinical Trial

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial

2022

COVID-19

InconclusiveReview/Other

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience

2022

Addiction

PositiveReview/Other

Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study

2022

COVID-19

NegativeReview/Other

Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review

2022

Addiction

PositiveLaboratory Study -

Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches

2022

COVID-19

InconclusiveReview/Other

Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort

2022

ADD and ADHD

Command Palette

Research Database

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

Parosmia COVID-19 Related Treated by a Combination of Olfactory Training and Ultramicronized PEA-LUT: A Prospective Randomized Controlled Trial

Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome

Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review

Prospective effects of loneliness on frequency of alcohol and marijuana use

Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants

Cannabinoids as Emergent Therapy Against COVID-19

Role of Cannabinoids in Various Diseases: A Review

Cannabinoids: Therapeutic Use in Clinical Practice

Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities

Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial

Over 1 year later: smokers' EVALI awareness, knowledge and perceived impact on e-cigarette interest

Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence

Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19

Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience

Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study

Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review

Agathis robusta Bark Essential Oil Effectiveness against COVID-19: Chemical Composition, In Silico and In Vitro Approaches

Is in-utero exposure to cannabis associated with the risk of attention deficit with or without hyperactivity disorder? A cohort study within the Quebec Pregnancy Cohort